Related Experiment Video
Updated: Jun 22, 2026

5/6th Nephrectomy in Combination with High Salt Diet and Nitric Oxide Synthase Inhibition to Induce Chronic Kidney Disease in the Lewis Rat
Published on: July 3, 2013
Effect of orchiectomy on renal function in control and diabetic rats with chronic inhibition of nitric oxide
Sharon Anderson1, Justin G Chapman, Terry T Oyama
1Division of Nephrology and Hypertension, Oregon Health and Science University, Portland, Oregon 97239-2940, USA.
Abstract:
1. Male gender is associated with higher blood pressure (BP) and more rapid loss of renal function in a spectrum of clinical and experimental renal diseases, including diabetic nephropathy. Consequently, modulation of testosterone levels could exert beneficial effects in the diabetic kidney. 2. The aim of the present study was to determine whether testosterone deficiency (orchiectomy) could influence BP and renal function in streptozotocin-diabetic rats, with or without accelerated endothelial dysfunction achieved by chronic inhibition of nitric oxide (NO) synthesis using N(G)-nitro-L-arginine methyl ester (l-NAME; 40-100 mg/L in the drinking water for 2 weeks), as well as in age-matched non-diabetic rats subjected to the same interventions. 3. Orchiectomy did not affect L-NAME-induced increases in BP in non-diabetic or diabetic rats. In non-diabetic rats, orchiectomy prevented L-NAME-induced increases in proteinuria. These effects on proteinuria were not observed in diabetic rats. In non-diabetic rats, orchiectomy had no effect on renal haemodynamics in animals receiving vehicle and did not affect L-NAME-induced changes in renal haemodynamics, characterized by reductions in renal plasma flow (RPF) and higher filtration fractions (FF). In intact diabetic rats, L-NAME treatment resulted in lower RPF. This difference was not observed in diabetic rats subjected to orchiectomy, although L-NAME-treated diabetic orchiectomized rats had lower RPF and higher FF compared with vehicle-treated intact diabetic rats. 4. In conclusion, we report modest beneficial effects of orchiectomy on proteinuria in normal, but not in diabetic, rats with inhibition of NO production. This suggests that testosterone reduction does not attenuate the deleterious impact of the diabetic metabolic milieu in the kidney.
Insights
Testosterone deficiency (orchiectomy) showed minor benefits for proteinuria in normal rats but not in diabetic rats with inhibited nitric oxide (NO) production. This indicates testosterone reduction does not protect the diabetic kidney.
Area of Science:
- Nephrology
- Endocrinology
- Urology
Background:
- Male gender is linked to higher blood pressure (BP) and faster kidney function decline in diseases like diabetic nephropathy.
- Modulating testosterone levels may offer protective effects for the diabetic kidney.
Purpose of the Study:
- To investigate the influence of testosterone deficiency (orchiectomy) on BP and renal function in streptozotocin-diabetic rats.
- To assess these effects with and without nitric oxide (NO) synthesis inhibition (using N(G)-nitro-L-arginine methyl ester [l-NAME]) in both diabetic and non-diabetic rats.
Main Methods:
- Orchiectomy was performed on streptozotocin-diabetic and age-matched non-diabetic rats.
- Rats received either l-NAME or a vehicle control in their drinking water for two weeks.
- Blood pressure, proteinuria, renal plasma flow (RPF), and filtration fraction (FF) were measured.
Main Results:
- Orchiectomy did not alter l-NAME-induced increases in BP in either diabetic or non-diabetic rats.
- In non-diabetic rats, orchiectomy attenuated l-NAME-induced proteinuria; this effect was absent in diabetic rats.
- While l-NAME reduced RPF in intact diabetic rats, this was not observed in orchiectomized diabetic rats, though they still showed impaired renal hemodynamics compared to controls.
Conclusions:
- Orchiectomy provided modest benefits for proteinuria in normal rats with inhibited NO production, but not in diabetic rats.
- Testosterone reduction does not mitigate the detrimental effects of the diabetic metabolic state on the kidney.

